Global Acute Migraine Drugs Market Report 2023: A $14.06 Billion Market by 2028 Featuring Key Players - Eli Lilly and Co, GSK, Bayer, J&J, Teva, AbbVie, Novartis, Merck, Pfizer, & Boehringer Ingelheim
March 10, 2023 05:53 ET
|
Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By...
United Kingdom Acute Migraine Drugs Market Report to 2028 - Prospects, Trends Analysis, Market Size and Forecasts
February 08, 2023 13:13 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "the United Kingdom Acute Migraine Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028" report has been added to ...
Global Migraine Drugs Market 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
January 11, 2023 05:28 ET
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Acute Migraine Drugs Market Report to 2028 - Featuring Endo Pharmaceuticals, Allergan, Impax Laboratories and Amgen Among Others
November 15, 2022 05:48 ET
|
Research and Markets
Dublin, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The "Acute Migraine Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ...
Worldwide Migraine Drugs Industry to 2026 - Featuring Allergan, Amgen and Eisai Among Others
October 22, 2021 08:33 ET
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global Migraine Drugs Markets, 2018-2019 & 2020-2026: Macro Indicator Analysis, Therapeutic Class, Treatment Type, Competitive Landscape
February 10, 2021 04:53 ET
|
Research and Markets
Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's...
United States Migraine Market and Competitive Landscape Report 2021-2026: Pipeline Products, Epidemiology, Market Valuations and Forecast, Drugs Sales and Competitive Landscape
January 19, 2021 04:18 ET
|
Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "US Migraine Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Migraine Market and Competitive...
Migraine Pipeline Review, H2 2020: Therapeutics Development & Assessment, Drug Profiles, Dormant Projects, Discontinued Products, Development Milestones, Competitive Landscape
December 23, 2020 08:38 ET
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Migraine - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Migraine - Pipeline Review, H2 2020,...
Global Migraine Drugs Market to 2025: Growing Demand for Electrical Nerve Stimulating Devices to Treat Migraine
December 15, 2020 05:08 ET
|
Research and Markets
Dublin, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Global $5.1 Bn Migraine Drugs Market 2020-2024 by Mode of Administration, Treatment Class & Regions
October 27, 2020 07:53 ET
|
Research and Markets
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "Global Migraine Drugs Market (by Mode of Administration, Treatment Class & Regions): Insights and Forecast with Potential Impact of COVID-19...